TransMedics Group, Inc. Convertible Debt, Noncurrent
TransMedics Group, Inc. (TMDX) had Convertible Debt, Noncurrent of $454.26 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2026-08-04
- 2026-06-30: Convertible Debt, Noncurrent $454.26M.
- 2026-03-31: Convertible Debt, Noncurrent $453.53M.
- 2025-12-31: Convertible Debt, Noncurrent $452.80M.
- 2025-09-30: Convertible Debt, Noncurrent $452.08M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2026-06-30 | $454.26M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $453.53M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $452.80M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $452.08M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $451.36M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $450.65M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $449.94M 10-K · filed 2026-02-24 |
| 2024-09-30 | $449.24M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $448.53M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $447.83M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $447.14M 10-K · filed 2025-02-27 |
| 2023-09-30 | $446.45M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $445.76M 10-Q · filed 2023-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |